Fontaine, H <br/><br/>
Anti-HBV DNA vaccination does not prevent relapse after discontinuation of analogues in the treatment of chronic hepatitis B: a randomised trial--ANRS HB02 VAC-ADN.  [electronic resource] 

 -  Gut  Jan 2015 
 - 139-47 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1468-3288 
<br/><br/><label>Standard No.: </label>10.1136/gutjnl-2013-305707  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antiviral Agents--therapeutic use<br/>Female<br/>Hepatitis B Vaccines<br/>Hepatitis B, Chronic--prevention & control<br/>Humans<br/>Male<br/>Middle Aged<br/>Prospective Studies<br/>Recurrence<br/>Treatment Failure<br/>Vaccines, DNA